Palatin Technologies (the developer) has launched a Phase II study in men with ED who are PDE5 inhibitor non-responders, using a new co-formulation of bremelanotide plus a PDE5i in a single injection
In conclusion, the resolution of leaky gut syndrome (a core mechanism underlying numerous systemic diseases) through BPC 157 therapy is a decisive argument that provides compelling evidence for the validity of its beneficial effects and supports the broader concept of cytoprotection [18] now described
(308) Oxytocin Troches as an Adjunctive Intervention to Conventional Testosterone and Erectile Dysfunction Medication for Men with Sexuality Concerns
Best Peptides for Weight Loss Right Now Liraglutide (Saxenda): The Original FDA-Approved GLP-1 Saxenda was the first GLP-1 medication ever approved by the FDA for chronic weight management, back in 2014, and it laid the groundwork for everything that came after it
Interventions that increase NAD+, including supplementing with NAD+ directly, may slow the aging process
therefore, the abundance and location of oxidizable substrates in cells determine the degree of lipid peroxidation and ferroptosis
